New country profile highlights urgent need for national heart failure strategy in the Netherlands

News & Events

27 November 2025
AUTHOR: HFPN Admin

Building on its ongoing work to advance heart failure policy, the Heart Failure Policy Network (HFPN) has published a new country profile focused on heart failure in the Netherlands. The profile was commissioned by the Netherlands Heart Institute as an addition to the existing Heart failure policy and practice in Europe series, designed to equip advocates and clinicians with evidence to drive meaningful change.

Heart failure is estimated to affect nearly 2% of the Dutch population, with around 500,000 people currently living with the condition – although almost half of them are unaware of their diagnosis. Each year, over 43,000 people are newly diagnosed, while over 8,000 people die because of heart failure.

Despite the scale of the issue, the Netherlands does not yet have a government-endorsed national strategy for heart failure or cardiovascular disease. HFPN’s country profile highlights the consequences of this gap and sets out priority actions to strengthen early diagnosis, integrate primary care and expand specialist workforce capacity. The report also showcases promising initiatives – such as the Deltaplan Heart Failure (Deltaplan Hartfalen) – that aim to improve awareness and coordination of care across the health system.

This country profile provides a clear policy narrative and benchmarking tool to support advocates in calling for a comprehensive national plan that places heart failure at the forefront of the health agenda in the Netherlands.

Project page

Download the country profile

Tagged:

More from News & Events

New guide for regional decision-makers in Spain aims to supp
New guide for regional decision-makers in Spain aims to supp...
10 April 2025
HFPN collaborated with leading experts in Spain to develop a three-step framework to support the transformation of heart failure service in line with the Spanish National Cardiovas...
Read article
Meet our members: Yvan Devaux
Meet our members: Yvan Devaux...
25 March 2025
We spoke to HFPN member Yvan Devaux, Head of the Cardiovascular Research Unit at the Luxembourg Institute of Health....
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, Bayer and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership. EU Transparency Register ID: 223430420230-66.